Matches in Wikidata for { <http://www.wikidata.org/entity/Q37289402> ?p ?o ?g. }
- Q37289402 description "article científic" @default.
- Q37289402 description "article scientifique" @default.
- Q37289402 description "articolo scientifico" @default.
- Q37289402 description "artigo científico" @default.
- Q37289402 description "artículu científicu espublizáu en 2009" @default.
- Q37289402 description "bilimsel makale" @default.
- Q37289402 description "scientific article published on August 2009" @default.
- Q37289402 description "vedecký článok" @default.
- Q37289402 description "vetenskaplig artikel" @default.
- Q37289402 description "videnskabelig artikel" @default.
- Q37289402 description "vědecký článek" @default.
- Q37289402 description "wetenschappelijk artikel" @default.
- Q37289402 description "wissenschaftlicher Artikel" @default.
- Q37289402 description "наукова стаття, опублікована в серпні 2009" @default.
- Q37289402 description "научни чланак" @default.
- Q37289402 description "مقالة علمية نشرت في أغسطس 2009" @default.
- Q37289402 name "Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab" @default.
- Q37289402 name "Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab" @default.
- Q37289402 name "Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting" @default.
- Q37289402 type Item @default.
- Q37289402 label "Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab" @default.
- Q37289402 label "Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab" @default.
- Q37289402 label "Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting" @default.
- Q37289402 prefLabel "Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab" @default.
- Q37289402 prefLabel "Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab" @default.
- Q37289402 prefLabel "Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting" @default.
- Q37289402 P1433 Q37289402-E7A3AB37-4176-4EB5-9C8A-BB22AD9221BE @default.
- Q37289402 P1476 Q37289402-7E1E84AD-D43E-4B6A-AFE4-8F279229EE8B @default.
- Q37289402 P2093 Q37289402-1A107608-A52B-4B1C-81BC-C6E84DFF5B6E @default.
- Q37289402 P2093 Q37289402-4A8196C0-FA34-42A4-A4DC-54F7468CF09F @default.
- Q37289402 P2093 Q37289402-5AFEE88C-E6C5-471D-912C-C2F882A64493 @default.
- Q37289402 P2093 Q37289402-9706C435-C48C-4D62-A00C-EF07D393EA4C @default.
- Q37289402 P2860 Q37289402-04E4E140-2EE6-4CCE-B8F1-2561102C675F @default.
- Q37289402 P2860 Q37289402-068D8CDA-C0C2-4FC0-9E0F-CD8716E10371 @default.
- Q37289402 P2860 Q37289402-175AB880-BE05-4275-B3FF-9B50B5FDEDBC @default.
- Q37289402 P2860 Q37289402-1A98B3C2-68EA-406C-B9EE-C549589CBE0D @default.
- Q37289402 P2860 Q37289402-1AB2E05A-165D-459F-A535-6B46F8694374 @default.
- Q37289402 P2860 Q37289402-1BFE2997-DFB3-46D3-BCFC-DFE5BAB45CB6 @default.
- Q37289402 P2860 Q37289402-22CA06E8-6622-43A7-9607-0EE75518D9B6 @default.
- Q37289402 P2860 Q37289402-29043DAE-B258-4285-A329-B631CC33AF43 @default.
- Q37289402 P2860 Q37289402-4634A09D-574E-440B-B75A-890411251BFB @default.
- Q37289402 P2860 Q37289402-4EFABF6A-9F7A-4932-B824-8CB1C138097C @default.
- Q37289402 P2860 Q37289402-61268530-ABB6-44B0-B47C-4F0A8FDA1556 @default.
- Q37289402 P2860 Q37289402-666CB327-1B76-4E34-9B56-4B941EBFA1C5 @default.
- Q37289402 P2860 Q37289402-66E79065-592B-47F5-B823-B685897496DE @default.
- Q37289402 P2860 Q37289402-6A42C449-0525-46D9-A40A-44F7943A9C51 @default.
- Q37289402 P2860 Q37289402-72E72371-83B6-415E-88B5-80DCAC98E271 @default.
- Q37289402 P2860 Q37289402-82A68C58-FA11-4122-B1EB-9DB3CE9E985C @default.
- Q37289402 P2860 Q37289402-9A010C28-19AD-47C4-991A-1415EA4FF8E3 @default.
- Q37289402 P2860 Q37289402-9BA3A71D-06BC-44D1-B1A2-B4312C1C7ADF @default.
- Q37289402 P2860 Q37289402-A52C5810-5080-4E0B-BB12-9E1646D76739 @default.
- Q37289402 P2860 Q37289402-A54BB610-FFE6-4D90-94F8-20633F2DC1D8 @default.
- Q37289402 P2860 Q37289402-A786B0E4-BC95-475D-8FCE-823363D9D49A @default.
- Q37289402 P2860 Q37289402-A86D722C-FF23-405F-B797-0ECCD8857883 @default.
- Q37289402 P2860 Q37289402-AD80532A-53AE-480F-A95B-EAA880B89EA3 @default.
- Q37289402 P2860 Q37289402-B342C0C0-77A5-4A3A-A583-22579095B412 @default.
- Q37289402 P2860 Q37289402-B407D53C-9B39-4635-88E7-CFB8BE60FDA8 @default.
- Q37289402 P2860 Q37289402-B8C002E7-7E17-4113-ACE5-96DA8BBE2149 @default.
- Q37289402 P2860 Q37289402-BBB370F2-DB72-4579-96FB-124185798C66 @default.
- Q37289402 P2860 Q37289402-C02CD55B-6CD1-4668-AB2F-E29A11ECABB8 @default.
- Q37289402 P2860 Q37289402-C65B44E5-9D26-49B9-9130-AA0C32573AAD @default.
- Q37289402 P2860 Q37289402-CBE0B690-D787-4DE4-8344-ADCA0F61C722 @default.
- Q37289402 P2860 Q37289402-CC3A8BB1-A7BE-4236-9231-531DB481B9B9 @default.
- Q37289402 P2860 Q37289402-E842B658-2908-496E-97B4-E875131EF692 @default.
- Q37289402 P2860 Q37289402-E9B7F68B-84CF-4D46-A72C-E5CB0DFD233A @default.
- Q37289402 P2860 Q37289402-F055ECE7-339A-41BE-A1BF-85C24928BA34 @default.
- Q37289402 P2860 Q37289402-F67B7A3E-F2A0-4C4F-A129-E7B6A1C0BDCF @default.
- Q37289402 P2860 Q37289402-F80330C9-1AE4-4596-A1B8-0C19472EC844 @default.
- Q37289402 P304 Q37289402-E529AD74-1516-45EA-BDF0-A9390B7B15BB @default.
- Q37289402 P31 Q37289402-98F6BC13-92E3-4F4A-80EF-B70FA419B993 @default.
- Q37289402 P356 Q37289402-1B3913D2-E389-4B04-A756-A6859CF9A037 @default.
- Q37289402 P433 Q37289402-F027628D-6F98-47B2-93C8-BA5A8FC0F3A0 @default.
- Q37289402 P478 Q37289402-8854B474-774A-4BB0-8EB4-A7585F89572A @default.
- Q37289402 P50 Q37289402-39020CBB-2B2C-4328-BE5B-F5AB4B5D6727 @default.
- Q37289402 P50 Q37289402-D31E23BA-0AC7-4C3F-9FCF-DC57D28D424B @default.
- Q37289402 P577 Q37289402-96DD4690-44F5-47DC-AF51-7B8BCB4DB0A7 @default.
- Q37289402 P5875 Q37289402-25B11452-17D8-4631-9459-EF5A2B23E377 @default.
- Q37289402 P698 Q37289402-1A0F4083-7E04-416F-97D5-9D759D547C57 @default.
- Q37289402 P921 Q37289402-7706DB49-4FDB-47CC-BCC6-A949613F0241 @default.
- Q37289402 P921 Q37289402-EE993133-BDEF-4F5E-BEE9-4F10BB9A4963 @default.
- Q37289402 P932 Q37289402-89D42025-5A0C-4C73-9726-6BE75D15906F @default.
- Q37289402 P356 J.NUCMEDBIO.2009.04.003 @default.
- Q37289402 P698 19647172 @default.
- Q37289402 P1433 Q7067979 @default.
- Q37289402 P1476 "Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab" @default.
- Q37289402 P2093 "Abraham Boskovitz" @default.
- Q37289402 P2093 "John H Sampson" @default.
- Q37289402 P2093 "Michael R Zalutsky" @default.
- Q37289402 P2093 "Tatsunori Okamura" @default.
- Q37289402 P2860 Q33589456 @default.
- Q37289402 P2860 Q33640550 @default.
- Q37289402 P2860 Q33705446 @default.
- Q37289402 P2860 Q33730975 @default.
- Q37289402 P2860 Q34135002 @default.
- Q37289402 P2860 Q34164704 @default.
- Q37289402 P2860 Q34483005 @default.
- Q37289402 P2860 Q36504207 @default.
- Q37289402 P2860 Q39316015 @default.
- Q37289402 P2860 Q40433287 @default.
- Q37289402 P2860 Q40500485 @default.